Ostrum Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.4M Buy
8,735
+1,250
+17% +$499K 0.16% 90
2026
Q2
$2.89M Buy
7,485
+120
+2% +$44.5K 0.14% 105
2026
Q1
$2.16M Sell
7,365
-613
-8% -$201K 0.12% 133
2025
Q4
$2.8M Sell
7,978
-1,529
-16% -$517K 0.13% 122
2025
Q3
$3.07M Sell
9,507
-6,673
-41% -$2.08M 0.14% 135
2025
Q2
$6.29M Buy
16,180
+5,340
+49% +$2.15M 0.29% 56
2025
Q1
$4.71M Buy
10,840
+6
+0.1% +$2.41K 0.25% 66
2024
Q4
$4M Sell
10,834
-320
-3% -$134K 0.35% 67
2024
Q3
$5.8M Sell
11,154
-210
-2% -$112K 0.48% 38
2024
Q2
$6.16M Sell
11,364
-1,110
-9% -$587K 0.54% 30
2024
Q1
$6.47M Buy
12,474
+523
+4% +$260K 0.51% 27
2023
Q4
$5.64M Sell
11,951
-272
-2% -$126K 0.49% 38
2023
Q3
$5.32M Sell
12,223
-29
-0.2% -$13.2K 0.49% 33
2023
Q2
$5.44M Sell
12,252
-216
-2% -$100K 0.46% 47
2023
Q1
$5.73M Buy
+12,468
New +$5.93M 0.5% 37

Other funds holding ELV

Ostrum Asset Management's ELV Position: Q3 2026 in Review

Ostrum Asset Management increased its Elevance Health (ELV) stake by 17% in Q3 2026, buying an estimated $499K and bringing the position to 8,735 shares worth $3.4M. The position accounts for 0.16% of the portfolio, ranked #90.

Ostrum Asset Management first reported a position in ELV in Q1 2023 and has held it in 15 quarters since. The position peaked at $6.47M in Q1 2024. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Ostrum Asset Management held 8,735 shares of Elevance Health worth $3.4M as of Q3 2026.
  • Ostrum Asset Management bought 1,250 Elevance Health shares in Q3 2026, an estimated $499K.
  • Elevance Health made up 0.16% of Ostrum Asset Management's portfolio in Q3 2026, its #90 holding.
  • Ostrum Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 15 quarters since.
  • Ostrum Asset Management's Elevance Health position peaked at $6.47M in Q1 2024.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Ostrum Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.